{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:13:39Z","timestamp":1788880419746,"version":"build-2803163510"},"reference-count":49,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,8]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Body composition analysis (BCA) provides an objective assessment of metabolic states, but its prognostic value in diffuse large B-cell lymphoma (DLBCL) remains unclear. We applied machine learning\u2013supported BCA to computed tomography imaging from patients with newly diagnosed DLBCL enrolled in the prospective phase 3 PETAL trial to quantify radiologic sarcopenia. We assessed BCA results in relation to survival after first-line immunochemotherapy, treatment-related hematologic toxicities, and molecular disease features. Patients in the lowest tertile of normalized skeletal muscle mass exhibited inferior survival after adjustment for established risk factors. Cause-specific time-to-event analyses revealed that sarcopenia was not associated with lymphoma-specific death but strongly predicted nonrelapse mortality, indicating a potential role as a biomarker of host vulnerability. Consistent with these findings, sarcopenic patients had a higher probability of experiencing hematologic toxicity during immunochemotherapy, and sarcopenia was the only independent risk factor for higher-grade hematotoxicity in multivariable analyses. Longitudinal BCA revealed inferior survival in patients with early muscle loss during therapy. Baseline sarcopenia and treatment-emergent muscle loss were not correlated, suggesting that these represent distinct biological phenomena, and only a small fraction of the interindividual variability in muscle mass could be attributed to age and lymphoma burden. Both phenotypes were independent of DLBCL molecular clusters, and no recurrently mutated gene was associated with lower skeletal muscle mass. Taken together, our results establish baseline sarcopenia and treatment-emergent muscle loss as orthogonal risk factors for adverse outcomes in DLBCL, supporting the evaluation of BCA for risk stratification in personalized lymphoma therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2026020504","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:32:06Z","timestamp":1787931126000},"page":"5995-6006","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["A machine learning\u2013derived sarcopenia index is associated with survival and nonrelapse mortality in DLBCL"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5033-2201","authenticated-orcid":false,"given":"Fabian","family":"Ullrich","sequence":"first","affiliation":[{"name":"1Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany"},{"name":"2Research Institute of Molecular Pathology, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1760-2342","authenticated-orcid":false,"given":"Ren\u00e9","family":"Hosch","sequence":"additional","affiliation":[{"name":"3Institute of Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany"},{"name":"4Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1920-0494","authenticated-orcid":false,"given":"Emre","family":"Kocakavuk","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany"},{"name":"3Institute of Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna K.","family":"Zieger","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3710-6840","authenticated-orcid":false,"given":"Paul W.","family":"Hotz","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Freund","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6825-702X","authenticated-orcid":false,"given":"Stefan K.","family":"Alig","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5706-9349","authenticated-orcid":false,"given":"Hans Christian","family":"Reinhardt","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany"},{"name":"5German Cancer Consortium (Partner Site Essen), University Hospital Essen, University Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"D\u00fchrsen","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2230-3873","authenticated-orcid":false,"given":"Andreas","family":"H\u00fcttmann","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5811-7100","authenticated-orcid":false,"given":"Felix","family":"Nensa","sequence":"additional","affiliation":[{"name":"3Institute of Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany"},{"name":"4Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1410-4487","authenticated-orcid":false,"given":"Bastian","family":"von Tresckow","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany"},{"name":"5German Cancer Consortium (Partner Site Essen), University Hospital Essen, University Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"issue":"9","key":"2026090811013069500_bib2","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse large B-cell lymphoma","volume":"384","author":"Sehn","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"2026090811013069500_bib3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.clml.2024.11.005","article-title":"SOHO state of the art updates and next questions | Diffuse large B-cell lymphoma in older adults: a comprehensive review","volume":"25","author":"Iyengar","year":"2025","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"14","key":"2026090811013069500_bib4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","author":"International Non-Hodgkin's Lymphoma Prognostic Factors Project","year":"1993","journal-title":"N Engl J Med"},{"key":"2026090811013069500_bib5","doi-asserted-by":"crossref","first-page":"e009462","DOI":"10.1136\/jitc-2024-009462","article-title":"Impact of immunological aging on T cell-mediated therapies in older adults with multiple myeloma and lymphoma","volume":"12","author":"Ullrich","year":"2024","journal-title":"J Immunother Cancer"},{"key":"2026090811013069500_bib6","doi-asserted-by":"crossref","first-page":"109943","DOI":"10.1016\/j.ejrad.2021.109943","article-title":"Methodology, clinical applications, and future directions of body composition analysis using computed tomography (CT) images: a review","volume":"145","author":"Tolonen","year":"2021","journal-title":"Eur J Radiol"},{"key":"2026090811013069500_bib7","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"2026090811013069500_bib8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"2026090811013069500_bib9","first-page":"100205","article-title":"An integrative review of cancer-related cachexia and sarcopenia: a different focus in malignant hematology","volume":"13","author":"Tinsley-Vance","year":"2024","journal-title":"Health Sci Rev"},{"key":"2026090811013069500_bib10","doi-asserted-by":"crossref","first-page":"102587","DOI":"10.1016\/j.arr.2024.102587","article-title":"Sarcopenia and the biological determinants of aging: a narrative review from a geroscience perspective","volume":"103","author":"Nunes-Pinto","year":"2025","journal-title":"Ageing Res Rev"},{"issue":"6","key":"2026090811013069500_bib11","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1200\/OP.20.00442","article-title":"How is geriatric assessment used in clinical practice for older adults with cancer? A survey of cancer providers by the American Society of Clinical Oncology","volume":"17","author":"Dale","year":"2021","journal-title":"JCO Oncol Pract"},{"issue":"4","key":"2026090811013069500_bib12","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41591-023-02232-8","article-title":"Body composition and lung cancer-associated cachexia in TRACERx","volume":"29","author":"Al-Sawaf","year":"2023","journal-title":"Nat Med"},{"issue":"1","key":"2026090811013069500_bib13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41746-025-02016-z","article-title":"Leveraging Sarcopenia index by automated CT body composition analysis for pan cancer prognostic stratification","volume":"8","author":"Borys","year":"2025","journal-title":"NPJ Digit Med"},{"issue":"1","key":"2026090811013069500_bib14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1186\/s12967-025-06507-1","article-title":"Fully volumetric body composition analysis for prognostic overall survival stratification in melanoma patients","volume":"23","author":"Borys","year":"2025","journal-title":"J Transl Med"},{"issue":"2","key":"2026090811013069500_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s43018-024-00891-1","article-title":"Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence","volume":"6","author":"Keyl","year":"2025","journal-title":"Nat Cancer"},{"issue":"4","key":"2026090811013069500_bib16","doi-asserted-by":"crossref","first-page":"e70021","DOI":"10.1002\/jcsm.70021","article-title":"Exploration of fully-automated body composition analysis using routine CT-staging of lung cancer patients for survival prognosis","volume":"16","author":"Kunnemann","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"10","key":"2026090811013069500_bib17","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1007\/s00277-023-05379-z","article-title":"Role of body composition and metabolic parameters extracted from baseline (18)F-FDG PET\/CT in patients with diffuse large B-cell lymphoma","volume":"102","author":"Chen","year":"2023","journal-title":"Ann Hematol"},{"issue":"5","key":"2026090811013069500_bib18","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/jcsm.12115","article-title":"Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"7","author":"Go","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"2026090811013069500_bib19","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3390\/curroncol28020126","article-title":"Body composition as a predictor of toxicity and prognosis in patients with diffuse large B-cell lymphoma receiving R-CHOP immunochemotherapy","volume":"28","author":"Guo","year":"2021","journal-title":"Curr Oncol"},{"issue":"7","key":"2026090811013069500_bib20","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s00277-023-05200-x","article-title":"Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B-cell lymphoma: results of a multicentric prospective cohort study","volume":"102","author":"Penichoux","year":"2023","journal-title":"Ann Hematol"},{"issue":"4","key":"2026090811013069500_bib21","doi-asserted-by":"crossref","first-page":"263.e1","DOI":"10.1016\/j.jtct.2023.01.015","article-title":"Sarcopenia predicts inferior progression-free survival in lymphoma patients treated with autologous hematopoietic stem cell transplantation","volume":"29","author":"Sumransub","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"13","key":"2026090811013069500_bib22","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1158\/1078-0432.CCR-24-3782","article-title":"Sarcopenia and skeletal muscle loss after CAR T-cell therapy in diffuse large B-cell lymphoma","volume":"31","author":"Jhaveri","year":"2025","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2026090811013069500_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1182\/bloodadvances.2024014555","article-title":"Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes","volume":"9","author":"Valtis","year":"2025","journal-title":"Blood Adv"},{"issue":"6","key":"2026090811013069500_bib24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1158\/2326-6066.CIR-22-0487","article-title":"Influence of adipose tissue distribution, sarcopenia, and nutritional status on clinical outcomes after CD19 CAR T-cell therapy","volume":"11","author":"Rejeski","year":"2023","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"2026090811013069500_bib25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/RLI.0000000000001040","article-title":"BOA: A CT-based body and organ analysis for radiologists at the point of care","volume":"59","author":"Haubold","year":"2024","journal-title":"Invest Radiol"},{"issue":"5","key":"2026090811013069500_bib26","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1158\/1078-0432.CCR-25-3080","article-title":"Deep learning-derived sarcopenia marker predicts benefit from anti-EGFR therapy in patients with RAS wild-type metastatic colorectal cancer","volume":"32","author":"Keyl","year":"2026","journal-title":"Clin Cancer Res"},{"issue":"20","key":"2026090811013069500_bib27","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1200\/JCO.2017.76.8093","article-title":"Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): a multicenter, randomized phase III trial","volume":"36","author":"Duhrsen","year":"2018","journal-title":"J Clin Oncol"},{"key":"2026090811013069500_bib28","first-page":"1753","article-title":"Quantitative oncology molecular analysis suite: ACCURATE","volume":"59","author":"Boellaard","year":"2018","journal-title":"J Nucl Med"},{"key":"2026090811013069500_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejca.2019.09.027","article-title":"Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: post-hoc analysis from the PETAL trial","volume":"124","author":"Schmitz","year":"2020","journal-title":"Eur J Cancer"},{"key":"2026090811013069500_bib30","doi-asserted-by":"crossref","first-page":"1746296","DOI":"10.3389\/fradi.2026.1746296","article-title":"Intravenous contrast medium impairs CT-based muscle quality but not quantity assessment: a translational study","volume":"6","author":"Salh\u00f6fer","year":"2026","journal-title":"Front Radiol"},{"issue":"1","key":"2026090811013069500_bib31","doi-asserted-by":"crossref","first-page":"e13741","DOI":"10.1002\/jcsm.13741","article-title":"The impact of radiation dose on CT-based body composition analysis: a large-animal study","volume":"16","author":"Salhofer","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"2026090811013069500_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41467-024-55614-y","article-title":"Integrating genetic subtypes with PET scan monitoring to predict outcome in diffuse large B-cell lymphoma","volume":"16","author":"Mendeville","year":"2025","journal-title":"Nat Commun"},{"issue":"18","key":"2026090811013069500_bib32","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"issue":"5","key":"2026090811013069500_bib33","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"issue":"4","key":"2026090811013069500_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"issue":"8","key":"2026090811013069500_bib35","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/bloodadvances.2021004286","article-title":"Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOP","volume":"5","author":"Eyre","year":"2021","journal-title":"Blood Adv"},{"issue":"4","key":"2026090811013069500_bib36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7326\/0003-4819-85-4-417","article-title":"Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma","volume":"85","author":"Schein","year":"1976","journal-title":"Ann Intern Med"},{"issue":"7","key":"2026090811013069500_bib37","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/ard.2008.092163","article-title":"Dose-related patterns of glucocorticoid-induced side effects","volume":"68","author":"Huscher","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"2026090811013069500_bib38","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1080\/10428194.2017.1410889","article-title":"Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration - a retrospective study","volume":"59","author":"Lamar","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"2026090811013069500_bib39","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/annonc\/mdm541","article-title":"Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma","volume":"19","author":"Ziepert","year":"2008","journal-title":"Ann Oncol"},{"issue":"25","key":"2026090811013069500_bib40","first-page":"3055","article-title":"Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma","volume":"141","author":"Eertink","year":"2023","journal-title":"Blood"},{"issue":"21","key":"2026090811013069500_bib41","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1200\/JCO.21.02063","article-title":"Proposed new dynamic prognostic index for diffuse large B-cell lymphoma: International Metabolic Prognostic Index","volume":"40","author":"Mikhaeel","year":"2022","journal-title":"J Clin Oncol"},{"issue":"6","key":"2026090811013069500_bib42","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1182\/blood.2023022020","article-title":"Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA","volume":"143","author":"Heger","year":"2024","journal-title":"Blood"},{"issue":"28","key":"2026090811013069500_bib43","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1200\/JCO.2018.78.5246","article-title":"Circulating tumor DNA measurements as early outcome predictors in diffuse large B-cell lymphoma","volume":"36","author":"Kurtz","year":"2018","journal-title":"J Clin Oncol"},{"issue":"23","key":"2026090811013069500_bib44","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1200\/JCO.20.02573","article-title":"Short diagnosis-to-treatment interval is associated with higher circulating tumor DNA levels in diffuse large B-cell lymphoma","volume":"39","author":"Alig","year":"2021","journal-title":"J Clin Oncol"},{"issue":"5","key":"2026090811013069500_bib45","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1470-2045(11)70069-9","article-title":"Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial","volume":"12","author":"Peyrade","year":"2011","journal-title":"Lancet Oncol"},{"issue":"6","key":"2026090811013069500_bib46","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.3324\/haematol.2019.245803","article-title":"Geriatric assessment in older patients with a hematologic malignancy: a systematic review","volume":"105","author":"Scheepers","year":"2020","journal-title":"Haematologica"},{"issue":"9","key":"2026090811013069500_bib47","first-page":"2454","article-title":"The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapy","volume":"108","author":"Isaksen","year":"2023","journal-title":"Haematologica"},{"issue":"11","key":"2026090811013069500_bib48","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1200\/JCO.20.02465","article-title":"Simplified geriatric assessment in older patients with diffuse large B-cell lymphoma: the prospective elderly project of the Fondazione Italiana Linfomi","volume":"39","author":"Merli","year":"2021","journal-title":"J Clin Oncol"},{"issue":"11","key":"2026090811013069500_bib49","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw145","article-title":"Longitudinal body composition changes in diffuse large B-cell lymphoma survivors: a retrospective cohort study of United States Veterans","volume":"108","author":"Xiao","year":"2016","journal-title":"J Natl Cancer Inst"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/17\/5995\/2541838\/blooda_adv-2026-020504-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/17\/5995\/2541838\/blooda_adv-2026-020504-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:02:31Z","timestamp":1788879751000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/17\/5995\/569467\/A-machine-learning-derived-sarcopenia-index-is"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":49,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2026,9,8]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2026020504","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9,8]]},"published":{"date-parts":[[2026,8,28]]}}}